Interim Report, April – June 2014 Improved operating

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Interim Report, April – June 2014

Improved operating margins and growth in Global Services revenues Operating profit, operating margin, earnings per share and cash flow from operations, all improved compared with the second quarter last year. Net sales for the second quarter amounted to SEK 104.0 (105.7) million, corresponding to a decline of 1.7 percent. Net sales are stable for the first six months of the year. Operating profit for the second quarter increased to SEK 22.7 (22.0) million, which is equivalent to an operating margin of 21.9 (20.8) percent. For the first six months of the year, operating profit increased to SEK 40.7 (36.0) million, corresponding to an operating margin of 19.9 (17.5) percent. Earnings per share increased to SEK 1.09 (1.04) for the second quarter and SEK 1.98 (1.74) for the first six months of the year. Cash flow from operations amounted to SEK 36.8 (36.2) million and SEK 59.8 (42.7) million for the first six months of the year. Cash and cash equivalents and financial investments amounted to SEK 172.2 (175.1) million at the end of the quarter. On 30 May, SEK 3.00 (3.00) per share was paid out via an automatic redemption program, equivalent to a transfer to the shareholders amounting to SEK 49.1 (49.4) million. April to June 2014 (second quarter previous year in brackets) · Net sales, SEK 104.0 (105.7) million · Growth, -1.7 (-12.3)% · Growth, currency adjusted, -2.2 (-9.6)% · Operating profit, SEK 22.7 (22.0) million · Operating margin, 21.9 (20.8)% · Net profit before tax, SEK 22.8 (23.4) million · Net profit after tax, SEK 17.8 (17.1) million · Earnings per share, SEK 1.09 (1.04) · Cash flow from operations, SEK 36.8 (36.2) million · Cash and cash equivalents and financial investments, SEK 172.2 (175.1) million January to June 2014 (January to June previous year in brackets) · Net sales, SEK 205.0 (205.1) million · Growth, -0.1 (13.8)% · Growth, currency adjusted, -0.2 (-11.5)% · Operating profit, SEK 40.7 (36.0) million · Operating margin, 19.9 (17.5)% · Net profit before tax, SEK 41.5 (38.6) million · Net profit after tax, SEK 32.2 (28.7) million · Earnings per share, SEK 1.98 (1.74) · Cash flow from operations, SEK 59.8 (42.7) million · Cash and cash equivalents, SEK 172.2 (175.1) million Anders Lidbeck, President and CEO comments: “Our operating margin for the second quarter was 21.9 percent. Once again we have set a record for profitability, this time for the second quarter. Never before has Enea had a better margin or greater earnings per share in the second quarter of a year. This is the fifth consecutive quarter with an improved operating profit year over year. It is also encouraging that we during the second quarter achieved a double digit revenue growth for our Global Services operation over the same period last year. This is the third quarter of sequential revenue growth, but it is the first time in six quarters we again achieve revenue growth year over year. We have won a range of major contracts in this line of business over the past few quarters, in both the US and Europe, which are now in full delivery mode. Our aim is to continue expanding this business, and we think that we are well positioned in our niche. Revenue from our software business remained stable throughout the first six months of the year, with a small increase in the first quarter and a corresponding decrease in the second quarter compared with the same periods last year. Our growth in this field is largely dependent on growth in royalty revenues from our major customers. We saw no major increase in these revenues during the second quarter due to weaker sales than anticipated among some of our major customers in the first quarter. However, our software business continues to develop with good gross margins and is making a strong contribution to the company’s overall operating profit. Our market position has also continued to develop well, as have ongoing discussions on new contracts, and we enter the second half year cautiously optimistic. We are the leading independent supplier of built-in operating system solutions in a world in which our competitors are becoming ever more vertically integrated and hence linked directly with specific kinds of hardware. We are continuing to focus on the ARM architecture, but we also benefit from our freedom as an independent software supplier. One specific example of this is the release of Enea Linux which took place during the quarter, as Enea Linux 4.0 supports hardware from a number of different suppliers, based on ARM, PowerPC and the x86 architecture. We are continuing to invest heavily in product development in order to continue improving our competitiveness. 22.6 percent of our revenues in the second quarter was reinvested in R&D, and we released a number of new products over the period. The second quarter was special as we launched new versions of all our major products – OSE5, Enea Linux and Element – simultaneously during one and the same quarter. We also finalized some completely new solutions, such as the OSE Compatibility Platform, which allows users to integrate OSE applications and Linux applications within a single system. This platform will be a key component for developing our business with existing customers and also enhancing our Linux range at the same time. To further strengthen our presence in the world of Linux, we also announced a strategic cooperation with the Linux Foundation during the quarter. As one of four selected global partners, we will be providing the Linux Foundation’s portfolio of training in the Embedded Linux field. The changes made to the sales and marketing organization in the US, which were implemented at the start of the second quarter, have developed well. We have also recruited a new manager for the Asian sales organization, and this person will start at the end of the third quarter. We will also be increasing our sales resources on the European market in the third quarter. We will continue to gradually strengthen our sales and marketing organization with the ambition to increase the growth rates long term, but without creating a negative impact on our operating margins short term. We continue our efforts to improve growth and high profitability. Our aim is to consolidate a 20 percent operating margin and deliver revenue growth year over year. We continue to be prepared for ongoing soft demand, but maintain our forecast for the year. Our estimate for the full year 2014 is that earnings per share will be improved compared with the previous year.” Press and analyst meeting Press and financial analysts are invited to a press and analyst meeting where Anders Lidbeck, President and CEO, will present and comment on the report. Time: Tuesday July 22 at 09:00 am CET. Link: http://financialhearings.nu/140722/enea/ Phone number: SE +46 851999350, UK +44 2031940547 The full report is published at www.enea.com/investors This information is such that Enea AB (publ) is to publish in accordance with the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on July 22, 2014 at 7.20 CET. For more information visit www.enea.com or contact Anders Lidbeck, President & CEO E-mail: anders.lidbeck@enea.com Sofie Sarhed, Investor Relations Phone: +46 709 71 4005 E-mail: sofie.sarhed@enea.com About Enea Enea is a global supplier of Linux and real-time operating system solutions, including middleware, tools, databases, and world class services, with a vision to enable communication everywhere. As a trusted and respected player in the embedded software eco system, Enea has for more than four decades delivered value and helped customers develop and maintain ground-breaking products. Every day, more than three billion people around the globe rely on Enea’s technologies in a wide range of applications in multiple verticals – from Telecom and Automotive, to Medical and Avionics. Enea has offices in Europe, North America and Asia, and is listed on NASDAQ OMX Nordic Exchange Stockholm AB. For more information please visit www.enea.com or contact us at info@enea.com Enea®, Enea OSE®, Netbricks®, Polyhedra® and Zealcore® are registered trademarks of Enea AB and its subsidiaries. Enea OSE®ck, Enea OSE® Epsilon, Enea® Element, Enea® Optima, Enea® Optima Log Analyzer, Enea® Black Box Recorder, Enea® LINX, Enea® Accelerator, Polyhedra® Lite, Enea® dSPEED Platform, Enea® System Manager and Embedded for Leaders(TM) are unregistered trademarks of Enea AB or its subsidiaries. Any other company, product or service names mentioned above are the registered or unregistered trademarks of their respective owner. © Enea AB 2014.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 271

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 135

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 255

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 410

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 325

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 190

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Kearney's 2025 Global Cities Report Insights

Updated Category News Views 654

Global Cities Adapt to New Challenges and Emergence Global cities hold steady at the top as new hubs surge forward Top cities reaffirm their dominance in the Global Cities Index, showcasing remarkable resilience amidst global changes and uncertainties. The Global Cities Outlook indicates a noticeable shift as traditional leaders face turbulence, while emerging Gulf and...

Continue Reading
Vacca Family Law Group Enhances Support for Peaceful Divorce

Updated Category News Views 255

Empowering Families Through Non-Adversarial Divorce Solutions Families navigating the challenging process of separation now have renewed access to considerate and non-confrontational divorce options. Vacca Family Law Group has recently welcomed Attorney and Mediator Wendy Reimer, who brings nearly two decades of experience in family law and a strong background in...

Continue Reading
Ingredion Delivers Impressive Q3 Results, Upgrades Outlook

Updated Category News Views 55

Ingredion's Strong Performance in the Third Quarter Ingredion Incorporated (NYSE: INGR) has reported remarkable results for the third quarter of 2024, showcasing a noteworthy surge in both operating income and earnings per share (EPS). The global leader in ingredient solutions for the food and beverage industry achieved a stunning 26% increase in reported operating income...

Continue Reading
Insight into Learning Technologies Group Plc's Disclosure Mechanism

Updated Category News Views 193

Understanding the Public Opening Position Disclosure Process In the complex world of financial securities, understanding the disclosure requirements can feel daunting. However, the process outlined by the Takeover Code, particularly Rule 8.3, provides a structured approach for individuals and entities holding significant interests in relevant securities. This rule is...

Continue Reading
Avidity Biosciences Set to Inspire with Latest Presentations

Updated Category News Views 191

Avidity Biosciences' Key Presentations at the MDA Conference Avidity Biosciences, Inc. (Nasdaq: RNA), a pioneer in RNA therapeutics, is poised to make a significant impact at the upcoming Clinical and Scientific Conference organized by the Muscular Dystrophy Association (MDA). The event will showcase the latest advancements in the field and highlight groundbreaking...

Continue Reading